Walgreens Boots Alliance’s APAC head Li Zhong warned at the Fortune Southeast Asia 500 Summit that Southeast Asian nations should avoid adopting the United States healthcare model, pointing out that while the U.S. pours 17 percent of its GDP into treatments, its population suffers from a shorter healthspan compared to regional peers.
Healthcare Cost Divergence and Regional Realities
- The United States allocates roughly $5.6 trillion—or 17 percent of its GDP—to healthcare, achieving high life extension through advanced therapies at the cost of overall healthspan efficiency.
- Vietnam spends a mere 4.6 percent of its GDP on health yet yields a comparable or superior healthspan for its citizens, according to regional industry evaluations.
- Southeast Asian healthcare operators are shifting focus toward community-based care models, primary clinic networks, and localized pharmacies to manage rising chronic disease rates amid specialist shortages.
The stark financial contrast underlines a growing debate over how developing markets should structure their medical infrastructure. Speaking in Ho Chi Minh City on November 3, fortune.com reported that Li Zhong highlighted the systemic pitfalls of American healthcare expenditure. While advanced therapeutic discovery remains the hallmark of the U.S. market, the resulting financial burden and reduced healthspan offer a flawed blueprint for emerging economies.
This structural divergence arrives as Thailand, Malaysia, Singapore, and Indonesia grapple with rapidly aging demographics and a steep climb in chronic illnesses. The financial and operational strain is compounded by acute workforce deficits. David Utama, president director of Indonesia’s largest private hospital chain Siloam Hospitals, outlined the severity of the regional physician gap.
Indonesia maintains a ratio of roughly 0.2 specialists per 1,000 people. Neighboring Malaysia and Thailand register nearly triple that capacity at 0.5 specialists per 1,000 people, while Singapore leads the regional density metrics at 1.2 specialists per 1,000 residents.
Community Clinic Expansion Versus Specialized Infrastructure
To bypass traditional capital expenditure bottlenecks associated with building large tertiary hospitals, operators across the region are pivoting toward decentralized primary care networks. Singapore- and Malaysia-headquartered IHH Healthcare manages more than 50 primary care clinics under its Parkway Shenton brand, embedding ambulatory, diagnostic, and rehabilitative services directly into residential areas.
Similarly, Siloam Hospitals is scaling its footprint through localized outpatient facilities. The organization operates 41 hospitals across Indonesia alongside a growing ecosystem of 25 primary care clinics spanning Jakarta, Bali, Surabaya, and Palembang.
Pharmacy networks are also slated to absorb routine clinical volume. Li pointed to the United Kingdom’s NHS Pharmacy First framework—which allows walk-in patient assessments for common ailments without a general practitioner appointment—as a viable template for Southeast Asia, provided regional pharmacists undergo rigorous clinical training.
| Healthcare Operator | Primary Market | Specialist Density / Primary Assets | Strategic Focus |
|---|---|---|---|
| Siloam Hospitals | Indonesia | 0.2 specialists per 1,000 people / 41 hospitals, 25 clinics | Enterprise AI deployment, community clinics |
| IHH Healthcare | Singapore, Malaysia | Singapore: 1.2 / Malaysia: 0.5 per 1,000 people | Parkway Shenton network expansion |
| Walgreens Boots Alliance (APAC) | Southeast Asia | Regional distribution and pharmacy networks | Pharmacy-led clinical assessment adoption |
Technology Integration and Public-Private Collaboration
Capitalizing on structural shifts requires direct coordination between state entities and private operators. Utama noted that while governments maintain distinct advantages in population access and funding scale, private enterprises drive operational capability, technological innovation, and deployment speed.
Enterprise artificial intelligence is central to this operational evolution. Since late 2025, Siloam Hospitals has committed capital toward foundational AI architecture, moving toward the implementation of predictive digital twins for patients, clinicians, and hospital facilities.
Data analytics platforms implemented within intensive care units now allow medical staff to predict patient deterioration 30 minutes before an acute drop occurs, replacing historical reactive interventions.
As Southeast Asian health systems continue to map out capital allocation for the remainder of the decade, the primary question remains whether decentralized primary care and localized public-private AI integration can successfully insulate emerging markets from the inflationary pressures plaguing Western healthcare expenditure.
Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.
